Skip to main content

Table 2 Univariate analysis for factors associated with mortality of patients with S. maltophilia bacteremia

From: Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate

Factor Overall
n (%)
(n = 68)
Death
n (%)
(n = 23)
Resolved
n (%)
(n = 45)
p value§
ICU admission prior to episode     
 Yes 28 (41.2%) 19 (82.6%) 9 (20%)  < 0.001**
 No 40 (58.8%) 4 (17.4%) 36 (80%)
Intubation prior to episode     
 Yes 23 (33.8%) 14 (60.9%) 9 (20.0%)  
 No 45 (66.2%) 9 (39.1%) 36 (80.0%)
Immunosuppressive therapy     
 Yes 22 (32.4%) 7 (30.4%) 15 (33.3%) 0.809
 No 46 (67.6%) 16 (69.6%) 30 (66.7%)
Chemotherapy     
 Yes 20 (29.4%) 7 (30.4%) 13 (28.9%) 0.895
 No 48 (70.6%) 16 (69.6%) 32 (71.1%)
Received meropenem     
 Yes 27 (39.7%) 15 (65.2%) 12 (26.7%)  
 No 41 (60.3%) 8 (34.8%) 33 (73.3%)
Organ transplant     
 Yes 22 (32.4%) 6 (26.1%) 16 (35.6%) 0.430
 No 46 (67.6%) 17 (73.9%) 29 (64.4%)
Steroid therapy     
 Yes 19 (27.9%) 7 (30.4%) 12 (26.7%) 0.743
 No 49 (72.1%) 16 (69.6%) 33 (73.3%)
Neutropenia     
 Yes 32 (47.1%) 16 (69.6%) 16 (35.6%)  
 No 36 (52.9%) 7 (30.4%) 29 (64.4%)
Central line     
 Yes 66 (97.1%) 23 (100.0%) 43 (95.6%) 0.305
 No 2 (2.9%) 0 2 (4.4%)
Platelet count     
 < 150 56 (82.4%) 23 (100%) 33 (73.3%)  
 ≥ 150 12 (17.6%) 0 12 (26.7%)
Positive respiratory culture     
 Yes 24 (35.3%) 17 (73.9%) 7 (15.6%) < 0.001**
 No 44 (64.7%) 6 (26.1%) 38 (84.4%)
Treatment with TMP/SMX     
 Monotherapy 36 (76.6%) 11 (73.3%) 25 (78.1%) 0.718
 Combination 11 (23.4%) 4 (26.7%) 7 (21.9%)
  1. §p value has been calculated using Chi-square test
  2. **Significant at p ≤ 0.05